Joanna Chorostowska‐Wynimko

Author

National Center for Tuberculosis and Lung Disease ORCID

Also Known As

Chorostowska-Wynimko, J., Chorostowska-Wynimko, Joanna, Chorostowska-Wynimko, Joanna; Samodzielna Pracownia Diagnostyki Molekularnej i Immunologii Instytutu Gruźlicy i Chorób Płuc w Warszawie, Gabriela Sokołowska, J Chorostowska-Wynimko, J. Chorostowska, J. Chorostowska-Wynimko, JOANNA CHOROSTOWSKA-WYNIMKO, Joanna Chorostowska, Joanna Chorostowska-Wynimko

329

Publications

2.9K

Citations

H-Index

124

Concepts

All Affiliations

National Center for Tuberculosis and Lung Disease Medizinische Hochschule Hannover Nicolaus Copernicus University German Center for Lung Research Narodowy Instytut Zdrowia Publicznego PZH – Państwowy Instytut Badawczy

About

Joanna Chorostowska‐Wynimko is an author at National Center for Tuberculosis and Lung Disease specializing in medicine, immunology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	29	880
2	Engineering	3	3	97
3	Health Sciences	2	2	65
4	Natural Sciences	2	2	82
5	Public Health	1	1	18

Joanna Chorostowska‐Wynimko

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE) Noel G. McElvaney, Jonathan Burdon, Mark Holmes, The Lancet Respiratory Medicine Open-label Extension TrialLong-term EfficacyImmunologyPulmonary PharmacologyMedicine	2016	191
Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease Adam Szpechciński, Joanna Chorostowska‐Wynimko, Radosław Struniawski, British Journal of Cancer	2015	149
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers Carolin V. Schneider, Karim Hamesch, Mattias Mandorfer, Gastroenterology Allelic VariantHepatologyGenotype-phenotype AssociationMedicineLiver Physiology	2020	92
Bacterial Immunostimulants—Mechanism of Action and Clinical Application in Respiratory Diseases Adriana Roży, Joanna Chorostowska‐Wynimko Advances in respiratory medicine	2008	77
Hepatobiliary phenotypes of adults with alpha-1 antitrypsin deficiency Malin Fromme, Carolin V. Schneider, Vítor Magno Pereira, Gut	2021	68
Validation of Lung EpiCheck, a novel methylation-based blood assay, for the detection of lung cancer in European and Chinese high-risk individuals Mina Gaga, Joanna Chorostowska‐Wynimko, Ildikó Horváth, European Respiratory Journal	2020	54
Diagnosis and management of α<sub>1</sub>-antitrypsin deficiency in Europe: an expert survey Ildikó Horváth, Maria Canotilho, J Chlumský, ERJ Open Research	2019	48
A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis. Joanna Chorostowska‐Wynimko, Rafal Swiercz, Ewa Skrzypczak‐Jankun, PubMed Chemoprevention StrategyTumor BiologyMedicinal ChemistryAngiogenesisCancer Cell Biology	2003	44
Increased interleukin-18 content and angiogenic activity of sera from diabetic (Type 2) patients with background retinopathy Piotr Skopiński, E Rogala, Barbara Duda-Król, Journal of Diabetes and its Complications InflammationDiabetic RetinopathyOcular DiseaseOphthalmologyDiabetes	2005	42
Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules Adam Szpechciński, Piotr Rudziński, Włodzimierz Kupis, Cancer Letters Chest Radiological FindingsEngineeringMedicineMultiple Pulmonary NodulePathology	2016	42

Page 1